Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
3
×
life sciences
national blog main
boston
boston blog main
boston top stories
accelerated approval
acute hepatic porphyria
aldehyde
aldeyra therapeutics
allergic conjunctivitis
alnylam pharmaceuticals
aminolevulinic acid
cannabidiol
dravet syndrome
dry eye disease
epidiolex
fda
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
lennox-gastaut syndrome
reproxalab
rna interference
san francisco
san francisco blog main
san francisco top stories
sjogren-larsson syndrome
zogenix
What
data
3
×
drug
medicine
3
×
fda
market
new
pharmaceuticals
ago
aldeyra
alnylam
approved
battle
cannabis
cleared
closer
derivative
disclosed
epilepsy
eye
far
fighting
filing
form
gw
gw’s
inflammation
interference
marijuana
multiple
nasdaq
ok
phase
positive
puts
rare
results
rna
rnai
second
seek
Language
Current search:
drugs
×
medicine
×
data
×
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug